glp-1 weight loss drug news today 2025 Yes, you heard that right — Zepbound just got a major price drop. 🎉, Eli Lilly said “new year, new numbers,” and honestly… we’re here for it. Lower cost, same powerful results for metabolic health and Yearender: Health | After splash

[PubMed]2

If weight loss as stalled - despite diet, exercise, or medications - the problem is usually metabolic signaling, not effort

Based on VigiBase, the World Health Organizations (WHO) adverse drug reaction database, intestinal obstructions are reported over 4.5 times more frequently with incretin-based drugs than with other diabetes medications [10]

Government Support and Policy Initiatives Recognizing the need for accessible obesity treatments, India plans to offer incentives under the Production Linked Incentive (PLI) scheme to promote the local manufacturing of GLP-1 drugs in 2026

Was sagt die Wissenschaft

Food and Drug Administration-approved medications